Ronald T Piervincenzi
CHIEF EXECUTIVE OFFICER & EX-OFFICIO at UNITED STATES PHARMACOPEIAL CONVENTION · MD · Healthcare
$1.1M
Peak Total Compensation
6
Years Tracked
15x
vs. Median Household
Ronald T Piervincenzi has appeared in compensation disclosures over 6 years of available data (2016–2025). Total compensation changed from $922,324 to $1,104,534 - a 19.8% increase.
Peak total compensation of $1,104,534 equals 15x the median U.S. household income ($75,000).
Compensation History
Year-by-Year Detail
| Year | Organization | Title | Compensation | Other | Total |
|---|---|---|---|---|---|
| 2025 | UNITED STATES PHARMACOPEIAL CONVENTION | CHIEF EXECUTIVE OFFICER & EX-OFFICIO | $975,149 | $129,385 | $1,104,534 |
| 2020 | United States Pharmacopeial Convention | Chief Executive Officer | $831,822 | $112,584 | $944,406 |
| 2019 | United States Pharmacopeial Convention | CEO | $868,419 | $135,471 | $1,003,890 |
| 2018 | United States Pharmacopeial Convention | CEO | $807,704 | $105,528 | $913,232 |
| 2017 | United States Pharmacopeial Convention | CEO | $767,830 | $94,704 | $862,534 |
| 2016 | United States Pharmacopeial Convention | CEO | $728,033 | $194,291 | $922,324 |
Peers at UNITED STATES PHARMACOPEIAL CONVENTION
| Name | Title | Peak Comp. |
|---|---|---|
| Susan S De Mars | Frmr Chf. Legal Off. -end 1/19 | $836K |
| Scott P Henderson | SVP, Info & Svcs - end 10/2/19 | $798K |
| Jakob Venema To 625 | EVP & CHIEF SCIENCE OFFICER | $708K |
| Roger L Williams Phd | Former CEO | $684K |
| Jakob Venema | EVP & CHIEF SCIENCE OFFICER | $629K |
| Anthony P Lakavage | SECRETARY & SVP GLBL EA | $628K |
| John A Giannone To 824 | VP, COMPENDIAL OPERATIONS | $611K |
| Amanda D Cowley | SVP, LEGAL, STRATEGY & PEOPLE | $609K |
| Stanley D Burhans | CHIEF FINANCIAL OFFICER | $590K |
| Emily M Kaine | SVP, GBL HEALTH & MANUFACTURING SVCS | $580K |
Email Alerts
Get notified about Ronald T Piervincenzi
Get an email when a new IRS Form 990 filing is posted that includes this executive. We send a confirmation link first - we don't add you to any other list.
Compare with another executive: Open comparison tool →